rf-fullcolor.png

 

February 25, 2014
by Alexander Gaffney, RAC

CDER Seeks Someone to Head up its Regulatory Policy Development Office

US pharmaceutical regulators in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) are looking to hire a new executive to head up its Office of Regulatory Policy (ORP).

The announcement, made in a 24 February 2014 posting on the USA Jobs website, calls for someone with legal training and at least five years of "specialized experience providing legal advice" on the development, interpretation or implementation of regulations, laws and policies.

The office is currently led by Acting Director Nancy Hayes and Deputy Director Carol Bennett, according to FDA's website.

CDER's listing notes that ORP is highly influential in crafting policies impacting a wide range of areas, including drug safety, clinical trials, new drug applications, over-the-counter medications, drug quality, good manufacturing practices, drug promotion and marketing, and more.

Applicants have until 24 March 2014 to submit their resumes for the position.

 

ORP Director Posting

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.